A Vial Container Closure System Performance Optimization Case Study Using Comprehensive Dimensional Stack-Up Analyses.

Cap Capping Container closure integrity (CCI) Container closure system (CCS) Dimensional Testing Modeling Performance Window Residual seal force (RSF) Seal Stopper Vial

Journal

PDA journal of pharmaceutical science and technology
ISSN: 1948-2124
Titre abrégé: PDA J Pharm Sci Technol
Pays: United States
ID NLM: 9439538

Informations de publication

Date de publication:
Historique:
pubmed: 16 2 2020
medline: 3 6 2021
entrez: 16 2 2020
Statut: ppublish

Résumé

Compatible vial container closure system (CCS) components in combination with a proper capping process are crucial to ensuring reliable performance, maintaining container closure integrity (CCI), and achieving CCS visual acceptance. CCI is essential for parenteral packaging and must be maintained throughout the entire sealed drug product life. In order to build the most robust CCS performance, many variables, including component selection, fit, function, and capping processes, must be set according to the actual dimensions of the CCS components used. However, conventional CCS stack-up calculations are based on dimensional engineering data and its tolerance from CCS component drawings without consideration of the real statistical distributions and their resultant impact on the risk of CCS end performance. CCS dimensional variations may lead to capping failure, resulting in CCS visual defects, CCI failure, and potentially costly destruction of an entire CCS production batch. In this paper, we demonstrated a comprehensive approach utilizing real CCS component dimensional data as a statistical input for CCS dimension stack-up calculations to calculate the actual CCS end performance window and the CCS's quantitative failure risk to determine the CCS's optimal sealing performance and visual acceptance under different stopper compression percentages. We examined two vial CCSs differing by the stopper as a case study. Each component was measured and included in comprehensive dimensional stack-up calculations. The resulting statistical distributions were used to examine component variability and stack-up assemblies at multiple stopper compressions and to identify the optimal CCS based on the performance window generated from the real data. Using this data-driven approach, we quantitatively identified that as little as 5% stopper compression difference could impact the CCS chosen. More importantly, comprehensive dimensional stack-up calculations can assist in selecting the best vial CCS and appropriate stopper compression, as well as troubleshoot processing concerns and ensure operation within the optimal CCS performance window.

Identifiants

pubmed: 32060224
pii: pdajpst.2019.010843
doi: 10.5731/pdajpst.2019.010843
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

368-376

Informations de copyright

© PDA, Inc. 2020.

Auteurs

Anthony Bucci (A)

West Pharmaceutical Services, Inc.

Le Ho (L)

West Pharmaceutical Services, Inc.

Lauren Orme (L)

West Pharmaceutical Services, Inc.

Qingyu Zeng (Q)

West Pharmaceutical Services, Inc. qingyu.zeng@westpharma.com.

Articles similaires

1.00
Humans Personnel Staffing and Scheduling Nursing Staff, Hospital Male Adult
Humans Neoplasms Male Female Middle Aged
Humans Patient Reported Outcome Measures Neoplasms Electronic Health Records Delivery of Health Care
Humans Retrospective Studies Male Critical Illness Female

Classifications MeSH